McKesson Co. (NYSE:MCK) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of McKesson Co. (NYSE:MCK - Get Free Report) have received an average rating of "Moderate Buy" from the sixteen analysts that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $645.79.

MCK has been the topic of a number of analyst reports. Wells Fargo & Company increased their price objective on shares of McKesson from $535.00 to $641.00 and gave the stock an "equal weight" rating in a research note on Friday, December 13th. Mizuho began coverage on shares of McKesson in a research report on Wednesday, December 4th. They set a "neutral" rating and a $630.00 price target on the stock. Evercore ISI boosted their price objective on shares of McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research report on Thursday, February 6th. Morgan Stanley upped their target price on McKesson from $612.00 to $642.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 17th. Finally, Bank of America decreased their price target on McKesson from $680.00 to $650.00 and set a "buy" rating on the stock in a research note on Monday, January 6th.

Insider Buying and Selling at McKesson

In related news, EVP Leann B. Smith sold 579 shares of the business's stock in a transaction on Monday, December 9th. The shares were sold at an average price of $602.81, for a total value of $349,026.99. Following the sale, the executive vice president now owns 1,443 shares of the company's stock, valued at $869,854.83. The trade was a 28.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In the last ninety days, insiders sold 1,346 shares of company stock worth $795,275. 0.11% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Millstone Evans Group LLC bought a new position in shares of McKesson during the fourth quarter worth about $28,000. Synergy Asset Management LLC acquired a new stake in McKesson during the 4th quarter valued at approximately $32,000. MidAtlantic Capital Management Inc. bought a new position in McKesson during the 3rd quarter worth approximately $29,000. Crews Bank & Trust acquired a new position in shares of McKesson in the 4th quarter worth approximately $33,000. Finally, Wolff Wiese Magana LLC boosted its stake in shares of McKesson by 742.9% in the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company's stock valued at $29,000 after purchasing an additional 52 shares during the last quarter. 85.07% of the stock is owned by institutional investors.

McKesson Stock Performance

Shares of MCK stock traded up $2.67 during trading on Friday, hitting $596.36. The company had a trading volume of 165,639 shares, compared to its average volume of 731,430. The stock's 50-day moving average price is $587.30 and its 200 day moving average price is $562.13. McKesson has a one year low of $464.42 and a one year high of $637.51. The firm has a market capitalization of $75.70 billion, a P/E ratio of 27.31, a price-to-earnings-growth ratio of 1.30 and a beta of 0.52.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. On average, research analysts anticipate that McKesson will post 32.69 earnings per share for the current fiscal year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be issued a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 0.48%. The ex-dividend date of this dividend is Monday, March 3rd. McKesson's payout ratio is 13.00%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.